11.08.25 -- Pharmaceutical Online Best Of October

As regulatory scrutiny intensifies, packaging components are taking center stage in pharmaceutical compliance. Join West experts to explore how USP <382> and the revised EU GMP Annex 1 redefine expectations for contamination control, extractables testing, and system-level validation. Gain practical insights on selecting and qualifying elastomeric components that withstand VHP decontamination while maintaining integrity—empowering manufacturers to make confident, data-driven packaging decisions. Click here to learn more.

J&J’s latest announcement follows its commitment in March to invest $55 billion to support U.S. manufacturing, R&D, and technology over the next four years.

The agency presents as a stepwise approach in which companies can make incremental investments rather than committing large amounts of capital upfront.

GLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.

Regulatory demands and patient well-being drive the necessity of aseptic techniques. Learn how these procedures, vital to pharmaceutical manufacturing, prevent contamination and ensure drug safety.

Predicting blending quality doesn't have to be a guessing game. Explore how to leverage virtual prototypes to make informed decisions and minimize costly trial-and-error in tablet manufacturing.

Gain essential insights into sterilization by exploring microbial inactivation kinetics, bacterial spore resistance, and key terminology—critical knowledge for ensuring product safety and compliance.